Open Access. Powered by Scholars. Published by Universities.®
- Publication Year
Articles 1 - 30 of 95
Full-Text Articles in Medicine and Health Sciences
Oncolog, Volume 63, Number 05-06, May - June 2018, Joe Munch, Sunita Patterson, Bryan Tutt
Oncolog, Volume 63, Number 05-06, May - June 2018, Joe Munch, Sunita Patterson, Bryan Tutt
OncoLog MD Anderson's Report to Physicians (All issues)
- Breast Cancer Treatment without Surgery: New approach may let certain breast cancer patients who respond to systemic therapy forgo surgery
- INBRIEF: Targeted Drug BLU-667 Shows Promise against Solid Tumors with RET Alterations
- Diet May Improve Gut Microbiome in Colorectal Cancer Survivors: Trial tests whether adding beans to diet affects markers of cancer risk, metabolic health
- TRK Inhibition Shows Activity in Solid Tumors: Early results of clinical trials for adult, pediatric patients with NTRK gene fusions show promise
- HOUSE CALL: Preparing for Natural Disasters-People with cancer or other chronic illnesses should take extra precautions
Oncolog, Volume 63. Number 03, March 2018, Bryan Tutt
Oncolog, Volume 63. Number 03, March 2018, Bryan Tutt
OncoLog MD Anderson's Report to Physicians (All issues)
- Local Consolidative Therapy Plus Immunotherapy or Targeted Agents for NSCLC: Clinical trials explore surgery/radiation plus immune checkpoint or tyrosine kinase inhibitors for metastatic non-small cell lung cancer
- INBRIEF: CAR T Cells Elicit Durable Responses in Large B Cell Lymphoma
- Managing Opioid Use in Cancer Patients: Vigilance and interventions ensure patient safety
- Hepatitis C Virus Linked to Head and Neck Cancers: Association of HCV with extrahepatic cancers has implications for HCV testing, treatment
- HOUSE CALL: Understanding cancer Risk and Risk factors-Your risk factors might affect your need for cancer screening
Oncolog, Volume 63, Number 01, January 2018, Bryan Tutt
Oncolog, Volume 63, Number 01, January 2018, Bryan Tutt
OncoLog MD Anderson's Report to Physicians (All issues)
- Immunotherapy for Genitourinary Cancers: Clinical trials explore immune checkpoint inhibitors for bladder, kidney, prostate cancers
- Active Surveillance for Ductal Carcinoma in Situ: COMET trial compares frequent mammography to standard treatment with surgery
- Radiation Plus Chemotherapy for Nasal NK T Cell Lymphoma: Clinical trial may standardize treatment for rare cancer
- HOUSE CALL: Mammography Is Essential for Breast cancer Screening- FDA warns against clinics that advertise screening without mammography
- USEFULRESOURCES: Videoconferences Allow Collaboration in Cancer Prevention, Treatment, Survivorship
Oncolog, Volume 62, Number 11-12, November - December 2017, Joe Munch, Bryan Tutt
Oncolog, Volume 62, Number 11-12, November - December 2017, Joe Munch, Bryan Tutt
OncoLog MD Anderson's Report to Physicians (All issues)
- Managing Chemotherapy-Induced Neuropathy: Neuromodulation, pharmacological treatments show promise against peripheral neuropathy in cancer patients.
- Treating Tobacco Addiction: MD Anderson provides pharmacotherapy, counseling to help smokers quit plus cessation education, resources for community practitioners
- HOUSE CALL: Smoking-Related Cancers- Cancer risks from tobacco are not limited to the lungs, but quitting reduces these risks
Oncolog, Volume 62, Number 10, October 2017, Sarah Bronson, Bryan Tutt
Oncolog, Volume 62, Number 10, October 2017, Sarah Bronson, Bryan Tutt
OncoLog MD Anderson's Report to Physicians (All issues)
- Organ-Sparing Therapy for Esophageal Cancer: Endoscopic surgery, ablation treat early-stage cancer, dysplasia while avoiding esophagectomy.
- INBRIEF: Surgeons Perform Unique Allogeneic Soft Tissue Transplant Between Identical Twins
- Advances in Breast Reconstruction: New reconstruction techniques increase breast cancer surgical options, improve cosmetic outcomes.
- HOUSE CALL: Facing the Financial Burden of Cancer Treatment-Talking to care team, seeking out resources are important steps in managing cancer-related financial stress
- INBRIEF: Proton Therapy plus Chemotherapy Shows Promise in Lung Cancer Trial
Oncolog, Volume 62, Number 08, August 2017, Bryan Tutt, Sarah Bronson
Oncolog, Volume 62, Number 08, August 2017, Bryan Tutt, Sarah Bronson
OncoLog MD Anderson's Report to Physicians (All issues)
- Immunotherapy for Smoldering Myeloma: Clinical trials test PD-1, DC38 inhibitors to delay progression from premalignant disease to multiple myeloma.
- Malignant Pheochromocytoma and Sympathetic Paraganglioma Research: Studies may expand treatment options for patients with rare neuroendocrine tumors.
- Hypofractionated Partial-Breast Irradiation: Clinical trial tests 10-day external-beam radiation therapy regimen after lumpectomy for patients with early-stage breast cancer.
- HOUSE CALL: Support for Cancer Patients: Patients, caregivers find many types of support from various organizations
Oncolog, Volume 62, Number 07, July 2017, Joe Munch, Bryan Tutt
Oncolog, Volume 62, Number 07, July 2017, Joe Munch, Bryan Tutt
OncoLog MD Anderson's Report to Physicians (All issues)
- RAS Mutations and Colorectal Cancer Liver Metastases: Gene mutations may have implications for local therapy for liver metastases from colorectal cancer.
- Active Surveillance for Prostate Cancer: Clinical trial may clarify which patients with prostate cancer will benefit from active surveillance rather than immediate treatment.
- Gut Microbiome May Affect Immunotherapy Response in Melanoma: Metastatic melanoma patients who experience responses to checkpoint inhibitors have a distinct gut bacterial genetic signature.
- HOUSE CALL: Cancer-Related fatigue-Tips for fighting fatigue
Oncolog, Volume 62, Number 04, April 2017, Bryan Tutt, Sarah Bronson
Oncolog, Volume 62, Number 04, April 2017, Bryan Tutt, Sarah Bronson
OncoLog MD Anderson's Report to Physicians (All issues)
- Advances in Surgical Management of Lymphedema: New options reduce edema in limbs, improve quality of life for cancer patients with lymphedema.
- Noncytotoxic First-Line Therapy for Mantle Cell Lymphoma: First-line therapy with targeted and immunotherapy agents produces high response rates in mantle cell lymphoma.
- Reports from the Survivorship Research Symposium: Research on BK virus, heart failure, and aspiration in cancer survivors.
- HOUSE CALL: Types of Immunotherapy for Cancer: Understanding different approaches to immunotherapy
Oncolog, Volume 61, Number 09, September 2016, Jill Delsigne-Russell, Brandon C. Strubberg, E Nielsen
Oncolog, Volume 61, Number 09, September 2016, Jill Delsigne-Russell, Brandon C. Strubberg, E Nielsen
OncoLog MD Anderson's Report to Physicians (All issues)
- Transport Oncophysics Could Guide Pancreatic Cancer Treatment: Pancreatic ductal adenocarcinomas respond poorly to standard treatments. Researchers at The University of Texas MD Anderson Cancer Center are applying the principles of physics to characterize the tumors, and these analyses could lead to individualized therapy.
- Nivolumab Shows Potential in Treating Squamous Cell Carcinoma of the Anal Canal: Currently, there are no standard therapy options for patients with treatment-refractory metastatic squamous cell carcinoma of the anal canal (SCCA), but early results of a multi-institutional clinical trial (No. NCI9673) led by researchers at The University of Texas MD Anderson Cancer Center show that the …
Oncolog, Volume 61, Number 07, July 2016, Bryan Tutt, Sarah Bronson, Laura Russell
Oncolog, Volume 61, Number 07, July 2016, Bryan Tutt, Sarah Bronson, Laura Russell
OncoLog MD Anderson's Report to Physicians (All issues)
- Improving Rates of Vaccination after Hematopoietic Stem Cell Transplant: Patients who have undergone a hematopoietic stem cell transplant (HSCT) for a hematological cancer usually lose the immunity they had acquired through vaccination. Although guidelines exist for vaccinating immunocompromised transplant recipients, many patients go unvaccinated or do not complete the series of vaccinations. An ongoing initiative at The University of Texas MD Anderson Cancer Center is using a multipronged approach to improve rates of vaccination after HSCT.
- Bone Loss Prevention in Patients with Cancer: Patients undergoing cancer treatment are at an increased risk of fractures because many cancer therapies tend to …
Oncolog, Volume 61, Number 04, April 2016, Joe Munch, Bryan Tutt, K Werner
Oncolog, Volume 61, Number 04, April 2016, Joe Munch, Bryan Tutt, K Werner
OncoLog MD Anderson's Report to Physicians (All issues)
- Aggressive Multimodality Salvage Therapy for Locally Recurrent Rectal Cancer Offers Hope to Patients: For patients with locally recurrent rectal cancer, multimodality salvage therapy presents the only chance for a cure. Such therapy is offered at just a handful of specialized referral institutions, including The University of Texas MD Anderson Cancer Center.
- Rapid Assessment, Clinical Trials Could Improve Outcomes for Anaplastic Thyroid Cancer Patients: Anaplastic thyroid cancer is extremely aggressive-only 20% of patients survive 1 year after their diagnosis-so patients require immediate assessment and treatment. A program at The University of Texas MD Anderson Cancer Center expedites the care of patients …
Oncolog, Volume 61, Number 01, January 2016, Sarah Bronson, Bryan Tutt, Bryan Tutt
Oncolog, Volume 61, Number 01, January 2016, Sarah Bronson, Bryan Tutt, Bryan Tutt
OncoLog MD Anderson's Report to Physicians (All issues)
- Proactive Management of Li-Fraumeni Syndrome Benefits Patients: Li-Fraumeni syndromes a hereditary disorder that confers an extremely high likelihood of developing cancer on affected individuals.
- Clinical Trial Tests High-Dose Radiation Therapy for Limited Stage Small Cell Lung Cancer: Small cell lung cancer carries a poor prognosis, even for patients without metastatic disease. But a phase III trial of high-dose daily or accelerated twice-daily thoracic radiation therapy for limited stage small cell kung cancer may lead to longer survival.
- Reducing Complications and Hospital Readmissions after Liver Surgery: Hepatectomy carries a risk of complications that can lead to hospital readmission and even death. …
Oncolog, Volume 60, Number 09, September 2015, Sarah Bronson, Bryan Tutt, K. Nair
Oncolog, Volume 60, Number 09, September 2015, Sarah Bronson, Bryan Tutt, K. Nair
OncoLog MD Anderson's Report to Physicians (All issues)
- Enhanced Surgical Recovery Programs Improve Perioperative Outcomes for Cancer Patients: For patients undergoing cancer surgery, potential complications and long recovery times can delay the delivery of additional life-saving therapy. To improve patients' perioperative outcomes and clear the way for timely administration of additional therapies, several surgical teams at The University of Texas MD Anderson Cancer Center gave begun using enhanced surgical recovery programs (ESRPs).
- New Treatments for Respiratory Viruses in Immunocompromised Patients: Viral respiratory infections are a major concern for immunocompromised patients, in whom such infections are difficult to treat and can lead to pneumonia and even death. Although few …
Oncolog, Volume 57, Number 05, May 2012, Bryan Tutt, Sunni Hosemann
Oncolog, Volume 57, Number 05, May 2012, Bryan Tutt, Sunni Hosemann
OncoLog MD Anderson's Report to Physicians (All issues)
- Advances in Gene Mapping Technology May Accelerate Cancer Drug Development: As new technology makes DNA sequencing faster and less expensive, researchers aim to exploit these abilities to develop novel targeted cancer therapies
- Compass: Advanced Renal Cell Carcinoma: Surgery and/or systemic therapy can help manage disease
- HOUSE CALL: Do Nutritional Supplements Help Prevent Cancer ?: For many people, the risks may outweigh the benefits
- INBRIEF: Drug Provides Symptom Reduction and Survival Advantages for Myelofibrosis Patients
Oncolog, Volume 57, Number 04, April 2012, Joe Munch, Bryan Tutt
Oncolog, Volume 57, Number 04, April 2012, Joe Munch, Bryan Tutt
OncoLog MD Anderson's Report to Physicians (All issues)
- Biology, More Than Chemotherapy Timing, Drives Locoregional Recurrence in Patients Who Undergo Breast-Conserving Therapy: The management of breast cancer, like that of many cancers, often requires a little bit of everything: surgery, radiation therapy, and systemic therapy with chemotherapeutic drugs or other agents
- New Treatments for Acute Myelogenous Leukemia May Improve Patient Outcomes: Acute myelogenous leukemia (AML) is an aggressive and deadly malignancy, nut new treatments are being developed that may prolong remissions
- HOUSE CALL: Controlling Nausea and Vomiting from Chemotherapy: Several techniques can be used to prevent or reduce this side effect
Oncolog, Volume 57, Number 01, January 2012, Joe Munch, Sunni Hosemann
Oncolog, Volume 57, Number 01, January 2012, Joe Munch, Sunni Hosemann
OncoLog MD Anderson's Report to Physicians (All issues)
- Meeting Needs of Cancer Survivors: Thanks to new treatments and early detection, many types of cancer can be cured or managed, and more cancer patients are surviving than in the past. These long-term survivors have unique health care needs that are just beginning to be understood.
- Compass: Locally Advanced Squamous Cell carcinoma of the Tonsil- Advances in surgical techniques may broaden treatment options for some patients.
- HOUSE CALL: Sex after Cancer Treatment- Many cancer-related sexual problems can be solved
Oncology, Volume 56, Number 10, October 2011, Bryan Tutt, Sunni Hosemann
Oncology, Volume 56, Number 10, October 2011, Bryan Tutt, Sunni Hosemann
OncoLog MD Anderson's Report to Physicians (All issues)
- Treating Cancer in Pregnant Patients: Pregnancy is usually a joyous, hopeful time; a cancer diagnosis can be devastating. When pregnancy and cancer occur together, they present special challenges for patients and physicians. Fortunately, these challenges often can be overcome by a multidisciplinary approach to treatment
- Compass: Non-Small Cell Lung Cancer: Stage IIIA-Many factors affect treatment sequences
- HOUSE CALL: Understanding Cancer Risk and Risk Factors: Your risk factors might affect your need for cancer screening
Oncology, Volume 56, Number 08, August 2011, Stephanie Deming, Sunni Hosemann
Oncology, Volume 56, Number 08, August 2011, Stephanie Deming, Sunni Hosemann
OncoLog MD Anderson's Report to Physicians (All issues)
- Addressing the Cardiac Complications of Cancer Treatment: Patients with cancer surviving longer than ever after treatment, and new targeted therapy agents are being introduced into the clinic with increasing frequency. These advances are cause for optimism, but they have also led to an increased incidence of cardiac complications of cancer therapy
- Compass: Early- and Intermediate-Stage Gastric Cancer: Neoadjuvant of adjuvant treatments offer higher cure rates than surgery alone
- HOUSE CALL: Managing Disease-Related Fatigue- Patients and doctors offer can make fatigue less severe
Oncolog, Volume 56, Number 07, July 2011, Kate Newberry, Joe Munch
Oncolog, Volume 56, Number 07, July 2011, Kate Newberry, Joe Munch
OncoLog MD Anderson's Report to Physicians (All issues)
- A New Era in Treating Patients Who Have Multiple Myeloma: During the past decade, several novel treatments have extended the median survival time for patients with multiple myeloma from less than 3 years to more than 7 years, and researchers are working to further improve treatment
- Landmark Trial Shows Potential of Low-Dose Computed Tomography for Lung Cancer Screening
- HOUSE CALL: Eating Healthier May Reduce Cancer Risk: Healthy eating habits may also increase energy and heart health
- IN BRIEF: Inotuzumab Ozogamicin Shows Promise for Acute Lymphoblastic Leukemia Treatment
Oncolog, Volume 56, Number 06, June 2011, John H. Mccool, Sunni Hoseman
Oncolog, Volume 56, Number 06, June 2011, John H. Mccool, Sunni Hoseman
OncoLog MD Anderson's Report to Physicians (All issues)
- MD Anderson Celebrates 70th Anniversary: Its first clinical facility was a converted Army barracks, its first headquarters was renovated residential estate near downtown Houston, and its first cancer research was conducted by four scientists in a former horse stable
- Compass: Stage II or III Soft Tissue Sarcoma-Chemotherapy and radiation therapy before or after surgery benefit patients
Oncolog, Volume 56, Number 03, March 2011, Bryan Tutt, Joe Munch
Oncolog, Volume 56, Number 03, March 2011, Bryan Tutt, Joe Munch
OncoLog MD Anderson's Report to Physicians (All issues)
- Glioblastoma Cure Remains Elusive Despite Treatment Advances: Aggressive surgery followed by radiation therapy and chemo-therapy offers hope of long-term survival for some patients with glioblastoma, but for most glioblastoma patients, the prognosis is poor
- Assessing and Addressing the Biological Effects of Stress in Cancer Patients: Stress has long been linked to cancer progression. But the precise mechanisms by which stress exacts its pro-tumor effects are not fully understood
- MD Anderson One of Four Centers to Test Cancer Cell Detection Chip: A new test that could monitor the effectiveness of cancer treatment
- HOUSE CALL: Yoga and Tai Chi: Two distinct disciplines …
Oncolog, Volume 56, Number 01, January 2011, Bryan Tutt, Sunni Hosemann
Oncolog, Volume 56, Number 01, January 2011, Bryan Tutt, Sunni Hosemann
OncoLog MD Anderson's Report to Physicians (All issues)
- New Drug Control Symptoms of Myeloproliferative Disorders and Improve Quality of Life for Patients: Recent clinical trials have demonstrated that a new class of drugs can effectively treat myeloproliferative disorders
- Compass: Metastatic Melanoma: Experimental treatments could be preferable to standard therapies for metastatic melanoma
- HOUS CALL: Breast Awareness: Guidelines recommend breast awareness rather than formal self-exams
Oncolog Volume 55, Number 11-12, November-December 2010, Bryan Tutt, Joe Munch
Oncolog Volume 55, Number 11-12, November-December 2010, Bryan Tutt, Joe Munch
OncoLog MD Anderson's Report to Physicians (All issues)
- Desmoid Tumors: Multidiciplinary treatment for an enigmatic disease
- Endoscopic Surgery for Skull Base Tumors: Patient selection is the key to success for the minimally invasive procedure
- INBRIEF: Earlier Breast Cancer Screening Recommended for Hispanic Women/SUMO Is Important for DNA Damage Repair/Regional Care Centers Make Cancer Treatment Easily Accessible/SIK2 Plays Critical Role in Chemotherapy Resistance
- HOUSE CALL: Books Provide Comfort, Guidence, Relaxation
Oncolog Volume 55, Number 10, October 2010, Sunni Hoseman, Stephanie Deming
Oncolog Volume 55, Number 10, October 2010, Sunni Hoseman, Stephanie Deming
OncoLog MD Anderson's Report to Physicians (All issues)
- Protecting the Patient during Radiation Theraphy: Staff expertise and equipment accuracy are essential to safe and effective treatment
- Compass Fall 2010: Stage II Colon Cancer: Adjuvant Therapy? After Surgery, some patients benefit from chemotherapy
- HOUSE CALL: Managing Cancer-Related Pain
- INBRIEF: Researchers identify Enzyme Involved in Chemotherapy Resistance
Oncolog Volume 55, Number 09, September 2010, Sunita Patterson, John Lebas
Oncolog Volume 55, Number 09, September 2010, Sunita Patterson, John Lebas
OncoLog MD Anderson's Report to Physicians (All issues)
- Tiny Particales, vast Potential-Coming soon to the clinic: nanoparticles that deliver therapy straight to tumor cells, bypassing normal cells and many toxic effects
- Non-Hodgkin Lymphomas: Targeted Therapies Leading Treatment Advances
- HOUSE CALL: Writing for Wellness: Keeping a Journal
- INBRIEF: Study Shows Abnormal Cells in Blood Increase with Lung Cancer Stage
Oncolog Volume 55, Number 07, July 2010, Joe Munch, Sunni Hoseman
Oncolog Volume 55, Number 07, July 2010, Joe Munch, Sunni Hoseman
OncoLog MD Anderson's Report to Physicians (All issues)
- Refining Approaches to Thyroid Cancer: Time-proven treatments and newer biologic agents offer hope, particularly for patirnts with advanced disease.
- Thyroid Cancer in Children.
- Compass Summer 2010: Locoregional Cancer of the Esophagus: Timimg Surgery and Other Therapies for Resectable Disease.
- HOUSE CALL: Understanding Clinical Trials
Oncolog Volume 55, Number 06, June 2010, John Lebas
Oncolog Volume 55, Number 06, June 2010, John Lebas
OncoLog MD Anderson's Report to Physicians (All issues)
- The BATTLE Results Are IN: Phase II trial reveals molecular signatures in lung cancer that may guide treatment decisions.
- Endoscopic Repair of Colon Perforations: Nonsurgical techniques for closing gestrointestinal defects may yiels benefits for patients undergoing colonoscopy.
- INBRIEF: Stem Cells Seen Repairing Heart Attack Damage Over Time/Additional Blood Data May Improve Pediatric Leukemia Predictions/Pediatric Patients with Rare Tumor May benefit from Heated Chemotherapy/New Findings Refute Link Between UVA, Melanoma.
- HOUSE CALL: Skin Cancer Screening: What is It and Who Should Get It ?: Types of skin cancer/Who should be screened ?/What to expect/Self-examination: Check your skin regularly and tell your …
Oncolog Volume 55, Number 04-05, April-May 2010, John Lebas, Sunni Hoseman
Oncolog Volume 55, Number 04-05, April-May 2010, John Lebas, Sunni Hoseman
OncoLog MD Anderson's Report to Physicians (All issues)
- IMAGING NERVES: Tetnus Toxin Offers Promise for Neurography
- INBRIEF: Fight-or-Flight Hormones Linked to Metastasis/Drug Combination Shows Promise for Colon Cancer Chemoprevention
- Compass Spring 2010: Early Uterine Papillary Serous Carcinoma: Treatment Options Tailored to Patient and Disease Characteristcs
- House Call: Addressing the Cosmetic Effects of Breast Cancer
Oncolog Volume 55, Number 03, March 2010, Bryan Tutt, Joe Munch
Oncolog Volume 55, Number 03, March 2010, Bryan Tutt, Joe Munch
OncoLog MD Anderson's Report to Physicians (All issues)
- Benign Tumors That Cause Big Problems:Fortunately, parathyroid tumors can be removed with minimally invasive surgery.
- Preventing Bone Loss nad Fractures in Cancer Patients
- INBRIEF: Leukemia Cells Observed Burning Fat to Evade Death/Assesment Tool Takes Aim at Graft-versus-Host Disease
- House call: Immunotherapy:Boosting the Body's Fight Against Cancer
Oncolog Volume 54, Number 11/12, November/December 2009, Dawn Chalaire, Joe Munch
Oncolog Volume 54, Number 11/12, November/December 2009, Dawn Chalaire, Joe Munch
OncoLog MD Anderson's Report to Physicians (All issues)
- Treating Neurofibromatosis
- Personalized Therapy for Lung Cancer
- House Call: Genetic Screening for Cancer Risks Gives Patients Options